A carregar...
Phase 1 Trials of rVSV Ebola Vaccine in Africa and Europe
BACKGROUND: The replication-competent recombinant vesicular stomatitis virus (rVSV)–based vaccine expressing a Zaire ebolavirus (ZEBOV) glycoprotein was selected for rapid safety and immunogenicity testing before its use in West Africa. METHODS: We performed three open-label, dose-escalation phase 1...
Na minha lista:
Publicado no: | N Engl J Med |
---|---|
Main Authors: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
Formato: | Artigo |
Idioma: | Inglês |
Publicado em: |
2015
|
Assuntos: | |
Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5490784/ https://ncbi.nlm.nih.gov/pubmed/25830326 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1056/NEJMoa1502924 |
Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|